| 609728 |
NEURO-ONCOLOGY |
EXTH-52. GLIOBLASTOMA-TARGETING AUTOLOGOUS INDUCED NEURAL STEM CELL THERAPY: EVALUATING SAFETY, TOXICITY, PERSISTENCE, AND TRANSPLANT METHODS IN A POST-SURGICAL CANINE MODEL | EXTH-52. GLIOBLASTOMA-TARGETING AUTOLOGOUS INDUCED NEURAL STEM CELL THERAPY: EV |
2020-11-01 |
10.1093/neuonc/noaa215.406 |
Bomba Hunter, Sheets Kevin, Valdivia Alain, Khagi Simon, Ruterbories Laura, Mariani Christopher, Borst Luke, Tokarz Debra, Hingtgen Shawn |
| 609727 |
NEURO-ONCOLOGY |
CBIO-03. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF CELL CYCLE PHASE TRANSITION | CBIO-03. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF CELL CYCLE PHASE TRANSITION |
2020-11-01 |
10.1093/neuonc/noaa215.063 |
Mullan Brendan, Qin Tingting, Siada Ruby, Ravindran Ramya, Thomas Chase, Harris Micah, Muruganand Ashwat, Pyaram Kalyani, Miklja Zachary, Reiber Mary, Garcia Taylor, Tran Dustin, Danussi Carla, Brosnan-Cashman Jackie, Pratt Drew, Zhao Xinyi, Rehemtulla Alnawaz, Sartor Maureen, Venneti Sriram, Meeker Alan, Huse Jason, Morgan Meredith, Lowenstein Pedro, Castro Maria, Yadav Viveka Nand, Koschmann Carl |
| 609726 |
NEURO-ONCOLOGY |
DDRE-26. TARGETING THE UNFOLDED PROTEIN RESPONSE POTENTIATES MARIZOMIB ANTITUMOR ACTIVITY IN GLIOBLASTOMA | DDRE-26. TARGETING THE UNFOLDED PROTEIN RESPONSE POTENTIATES MARIZOMIB ANTITUMOR ACTIVITY IN GLIOBLASTOMA |
2020-11-01 |
10.1093/neuonc/noaa215.271 |
Severin Christophe, Benitez-Hernandez Jorge, Dumitru C Dan, Beltran-Raygoza Nishdallyh, Flandin-Blety Pierre, Escoubet Laure, Rolfe Mark |
| 609725 |
NEURO-ONCOLOGY |
EPID-18. GLIOBLASTOMA CHARACTERIZATION IN FEMALES WITHIN RURAL PENNSYLVANIA: A SINGLE INSTITUTIONAL RETROSPECTIVE REVIEW | EPID-18. GLIOBLASTOMA CHARACTERIZATION IN FEMALES WITHIN RURAL PENNSYLVANIA: A SINGLE INSTITUTIONAL RETROSPECTIVE REVIEW |
2020-11-01 |
10.1093/neuonc/noaa215.336 |
Giombetti Maia, Jakubek Emilia, Gatson Na Tosha, Bross Shane |
| 609724 |
RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY |
OC-0231: Outcome impact of radiotherapy protocol compliance: RTQA results from the PET-Plan trial |
2020-11-01 |
10.1016/s0167-8140(21)00255-3 |
Schimek-Jasch T., Kremp S., Stockinger M., Küsters A., Hehr T., Bultel Y., Hass P., Fleckenstein J., Thieme A.H., Adebahr S., Gkika E., Duncker-Rohr V., Tosch M., Eschmann S.M., Miederer M., Holl G., Rischke H.C., Schaefer-Schuler A., König J., Broichhagen C., Lenz S., Binder H., Grosu A., Nestle U. |
| 609723 |
COMPUTATIONAL MATERIALS SCIENCE |
First-principles calculations on high-temperature desorption loss from iridium |
2020-11-01 |
10.1016/j.commatsci.2020.109897 |
Seo Insung, Yokota Shunsuke, Imai Yousuke, Gohda Yoshihiro |
| 609722 |
GYNECOLOGIC ONCOLOGY REPORTS |
COL1A1-PDGFB fusion uterine sarcoma and its response to Imatinib therapy |
2020-11-01 |
10.1016/j.gore.2020.100653 |
Grindstaff Samuel L., DiSilvestro Paul, Quddus M. Ruhul |
| 609721 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION : APJCP |
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma |
2020-11-01 |
10.31557/apjcp.2020.21.11.3345 |
Mohammed Salama Maha |
| 609720 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophages |
2020-11-01 |
10.1136/jitc-2020-001617 |
Hart Martin, Nickl Laura, Walch-Rueckheim Barbara, Krammes Lena, Rheinheimer Stefanie, Diener Caroline, Taenzer Tanja, Kehl Tim, Sester Martina, Lenhof Hans-Peter, Keller Andreas, Meese Eckart |
| 609719 |
BMJ OPEN |
Qualitative investigation of trace-based communication: how are traces conceptualised in healthcare teamwork? |
2020-11-01 |
10.1136/bmjopen-2020-038406 |
Cristancho Sayra, Field Emily |
